首頁 > 市場調查報告書 > 醫療設備

體外診斷

幽門螺旋桿菌（H. pylori）診斷市場規模、佔有率和成長分析（按檢測類型、方法、最終用戶和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1900109

幽門螺旋桿菌（H. pylori）診斷市場規模、佔有率和成長分析（按檢測類型、方法、最終用戶和地區分類）—產業預測（2026-2033 年）

Helicobacter pylori H. pylori Diagnostics Market Size, Share, and Growth Analysis, By Test Type (Invasive, Histology), By Method (Immunoassays, Molecular diagnostics), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球幽門螺旋桿菌（H. pylori）診斷市場規模預計在 2024 年達到 6.7475 億美元，從 2025 年的 7.2131 億美元成長到 2033 年的 12.3011 億美元，在預測期（2026-2033 年）複合年成長率為 6.9%。

由於幽門螺旋桿菌診斷有助於提高診斷準確性、促進有效治療並降低醫療成本，全球幽門螺旋桿菌診斷市場正蓬勃發展。透過先進的診斷檢測進行早期發現對於預防疾病進展和減輕幽門螺旋桿菌感染相關併發症至關重要。創新非侵入性檢測方法，例如血液檢測、呼吸檢測和糞便抗原檢測，不僅為患者提供了更高的便利性和舒適度，而且經濟實惠，從而促進了其更廣泛的應用。這種高效的診斷使醫療服務提供者能夠及時啟動治療，從而改善患者預後、緩解症狀並加速潰瘍癒合。此外，包括抗生素和抑酸劑在內的有效治療方案在預防嚴重併發症、改善患者整體健康狀況和生活品質方面發揮關鍵作用。

推動全球幽門螺旋桿菌診斷市場發展的因素

全球幽門螺旋桿菌診斷市場主要受幽門螺旋桿菌感染疾病在全球範圍內高發生率的推動。據估計，近一半的人口受到這種廣泛存在的細菌感染的影響。這種普遍性導致人們對精準診斷測試和有效治療方案的需求日益成長。隨著人們對幽門螺旋桿菌健康影響的認知不斷提高，對可靠診斷和適當感染控制的需求也變得愈發迫切。因此，醫療服務提供者和患者都開始尋求能夠實現及時介入的創新診斷方法，這凸顯了擴大市場和豐富治療選擇的迫切性。

全球幽門螺旋桿菌診斷市場限制因素

全球幽門螺旋桿菌診斷市場的擴張面臨許多挑戰，其中之一是許多發展中地區醫療資源和診斷能力的匱乏。這些地區往往缺乏準確診斷和治療幽門螺旋桿菌感染疾病所需的專業醫療設備和技術人員，限制了患者獲得基本醫療保健服務的機會。這種醫療資源分配的不均可能導致這些地區的人們難以獲得所需的醫療服務，最終從根本上影響幽門螺旋桿菌診斷的整體進展和發展，並嚴重阻礙市場成長。解決這些限制因素對於改善受影響地區的醫療保健狀況至關重要。

全球幽門螺旋桿菌（H. pylori）診斷市場趨勢

全球幽門螺旋桿菌（H. pylori）診斷市場正呈現出顯著的趨勢，即非侵入性檢測方法，特別是血清學檢測和尿素呼氣試驗，正日益普及。這項變化主要源自於患者對便利性、非侵入性檢測方法的偏好，以及診斷技術的進步提高了檢測的準確性和可靠性。隨著醫療機構致力於改善患者體驗和治療效果，對這些非侵入性檢測的需求激增，反映出人們對便捷高效診斷方法的普遍追求。這一趨勢不僅有助於早期發現和治療幽門螺旋桿菌感染疾病，也反映了全球民眾對胃腸道健康的日益重視。

賽默飛世爾科技（美國）
Bio-Rad Laboratories（美國）
Meridian Bioscience（美國）
F. Hoffmann-La Roche Ltd.（瑞士）
Quest Diagnostics Incorporated（美國）
雅培實驗室（美國）
生物梅里埃公司（法國）
康德樂公司（美國）
Epitope Diagnostics, Inc.（美國）
Biohit Oyj（芬蘭）
Avanos Medical, Inc.（美國）
Quidel公司（美國）
迪亞索林公司（義大利）
安捷倫科技公司（美國）
美國實驗室控股公司（LabCorp）（美國）
西門子醫療股份公司（德國）

結論與建議

簡介目錄

Product Code: SQMIG35A2188

Global Helicobacter pylori H. pylori Diagnostics Market size was valued at USD 674.75 Million in 2024 and is poised to grow from USD 721.31 Million in 2025 to USD 1230.11 Million by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global diagnostics market for Helicobacter pylori is gaining traction due to its role in enhancing diagnosis, enabling effective treatment, and lowering healthcare expenses. Early detection through advanced diagnostic tests is vital for preventing disease progression and mitigating complications associated with H. pylori infections. Innovative, non-invasive testing methods such as blood, breath, and stool antigen tests make detection accessible and comfortable for patients, while being cost-effective and increasing availability across broader demographics. This diagnostic efficiency allows healthcare providers to initiate timely treatment, yielding improved patient outcomes, symptom relief, and faster healing of ulcers. Additionally, effective treatment options, including antibiotics and acid-reducing medications, play a critical role in thwarting severe complications, thus enhancing patients' overall health and quality of life.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Helicobacter pylori H. pylori Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Helicobacter pylori H. pylori Diagnostics Market Segments Analysis

Global Helicobacter pylori H. pylori Diagnostics Market is segmented by Test Type, Method, End User and region. Based on Test Type, the market is segmented into Invasive, Histology, Rapid Urease Test, HP Culture, Non-Invasive, Serologic Test, Urea Breath Test and Stool Antigen Test. Based on Method, the market is segmented into Immunoassays, Molecular diagnostics, Point of Care (POC) and Others. Based on End User, the market is segmented into Hospitals, Clinics, Diagnostic Labs and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Helicobacter pylori H. pylori Diagnostics Market

The global Helicobacter pylori diagnostics market is driven by the high incidence of H. pylori infections worldwide, with nearly half of the population estimated to be affected by this prevalent bacterial infection. This widespread occurrence has led to an increasing demand for accurate diagnostic tests and effective treatment solutions. As awareness of H. pylori's health implications grows, the need for reliable diagnosis and appropriate management of the infection becomes more critical. Consequently, healthcare providers and patients alike are seeking innovative diagnostics that can lead to timely interventions, underscoring the market's expansion and the urgency for enhanced treatment options.

Restraints in the Global Helicobacter pylori H. pylori Diagnostics Market

The expansion of the global H. pylori diagnostics market faces challenges due to inadequate healthcare resources and diagnostic capabilities in various developing regions. Access to specialized medical equipment and expertise needed for the accurate diagnosis and treatment of H. pylori infections is often scarce, limiting patient access to essential healthcare services. This disparity in availability can significantly hinder market growth, as individuals in these areas may struggle to receive the necessary medical attention, ultimately affecting the overall progress and development of H. pylori diagnostics on a broader scale. Addressing these constraints is crucial for improving healthcare outcomes in affected regions.

Market Trends of the Global Helicobacter pylori H. pylori Diagnostics Market

The Global Helicobacter pylori (H. pylori) diagnostics market is experiencing a significant trend towards increased adoption of non-invasive methods, particularly serology tests and urea breath tests. This shift is largely driven by patient preference for convenient and less invasive procedures, alongside advancements in diagnostic technology that enhance accuracy and reliability. As healthcare providers focus on improving patient experiences and outcomes, the demand for these non-invasive tests is surging, reflecting a broader movement towards accessible and efficient diagnostics. This trend not only facilitates early detection and treatment of H. pylori infections but also signifies a growing awareness of gastrointestinal health among populations worldwide.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Helicobacter pylori H. pylori Diagnostics Market Size by Test Type & CAGR (2026-2033)

Market Overview
Invasive
Histology
Rapid Urease Test
HP Culture
Non-Invasive
Serologic Test
Urea Breath Test
Stool Antigen Test

Global Helicobacter pylori H. pylori Diagnostics Market Size by Method & CAGR (2026-2033)

Market Overview
Immunoassays
Molecular diagnostics
Point of Care (POC)
Others

Global Helicobacter pylori H. pylori Diagnostics Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Clinics
Diagnostic Labs
Others

Global Helicobacter pylori H. pylori Diagnostics Market Size & CAGR (2026-2033)

North America (Test Type, Method, End User)
- US
- Canada
Europe (Test Type, Method, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Test Type, Method, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Test Type, Method, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Test Type, Method, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Epitope Diagnostics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biohit Oyj (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avanos Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings (LabCorp) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments